Dehydroquinate dehydratase (DHQD) catalyzes the third step in the biosynthetic shikimate pathway. We present three crystal structures of the Salmonella enterica type I DHQD which address the functionality of a surface loop that is observed to close over the active site following substrate binding. Two wild type structures with differing loop conformations and kinetic and structural studies of a mutant provide evidence of both direct and indirect mechanisms of loop involvement in substrate binding. In addition to allowing amino acid side chains to establish a direct interaction with the substrate, loop closure necessitates a conformational change of a key active site arginine, which in turn positions the substrate productively. The absence of DHQD in humans and its essentiality in many pathogenic bacteria makes the enzyme a target for the development of nontoxic antimicrobials. The structures and ligand binding insights presented here may inform the design of novel type I DHQD inhibiting molecules.The seven enzymes of the shikimate pathway catalyze sequential reactions to generate chorismate -a crucial branch point in the synthesis of the aromatic amino acids (1). Due to the essentiality of the shikimate pathway enzymes in a number of organisms and the absence † The Center for Structural Genomics of Infectious Diseases has been funded in whole or in part with federal funds from the National of mammalian shikimate homologs, the shikimate pathway has been regarded as a viable target for the development of novel non-toxic antimicrobials, anti-fungals, and herbicides (2-5).The dehydration of dehydroquinate to dehydroshikimate represents the third step in the shikimate pathway (Figure 1). Biochemical and genetic studies have shown this reaction can be catalyzed by two phylogenetically unrelated enzyme families (6). Type I dehydroquinate dehydratases (DHQDs) are found in plants, fungi, and some bacterial species (7,8). In bacteria, these ~29 kDa enzymes assemble into homo-dimers and catalyze a reaction which proceeds via a covalent Schiff base intermediate to result in a cis-elimination (9-11). Distinct from type I enzymes, type II DHQDs are found exclusively within bacteria. Thesẽ 17 kDa enzymes assemble into homo-dodecamers and catalyze a reaction that proceeds via a non-covalent enolate intermediate to result in a trans-elimination (12-14).We recently reported crystal structures of the Samonella enterica type I DHQD in binary complex with the substrate 3-dehydroquinate in both a non-covalent pre-Schiff base state and a covalent Schiff base bound reaction intermediate state (15). In addition, we analyzed the Clostridium difficile type I DHQD in covalent Schiff base bound complex with the product 3-dehydroshikimate (15). These crystal structures provided crucial insight into the reaction mechanism, suggesting that a single active site histidine cycles through multiple protonation events to catalyze the reaction and the formation/hydrolysis of the Schiff base intermediate (15). Notably, these DHQD complexes con...